Sort
23,748 grants matching “melanoma”
NO in Tumor Angiogenesis,Microcirculation & Rad.Therapy
$288,015Dai Fukumura · Massachusetts General Hospital · R01 · FY2006 · CA
Safety and Efficacy of Vemurafenib and High-Dose InterferonAlpha-2b for Advanced
$288,007Soldano Ferrone · University Of Pittsburgh At Pittsburgh · P50 · FY2013 · CA
Modulation of Microglia and T Cell Interactions in Malignant Glioma
$288,000Amy Beth Heimberger · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA
Regulation of p53 acetylation and deacetylation in tumorigenesis
$288,000Wei Gu · Columbia University Health Sciences · R01 · FY2017 · CA
Modulation of Microglia and T Cell Interactions in Malignant Glioma
$288,000Amy Beth Heimberger · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
Regulation of p53 acetylation and deacetylation in tumorigenesis
$288,000Wei Gu · Columbia University Health Sciences · R01 · FY2015 · CA
Modulation of Microglia and T Cell Interactions in Malignant Glioma
$288,000Amy Beth Heimberger · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · CA
Regulation of p53 acetylation and deacetylation in tumorigenesis
$288,000Wei Gu · Columbia University Health Sciences · R01 · FY2016 · CA
Modulation of Microglia and T Cell Interactions in Malignant Glioma
$288,000Amy Beth Heimberger · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Regulation of p53 acetylation and deacetylation in tumorigenesis
$288,000Wei Gu · Columbia University Health Sciences · R01 · FY2014 · CA
Core 2: Biospecimen Core
$287,956Ruth Halaban · Yale University · P50 · FY2018 · CA
Effect of Tumor Derived TGF B on Dendritic Cell Vaccines
$287,850University Of Arizona · R01 · FY2005 · CA
Augmenting the Immunogenicity of Melanoma Through Manipulation of Histone Deacet
$287,702Eduardo M Sotomayor · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2017 · CA
Catheter-Based Ultrasound Hyperthermia System for 3D-Targeted Thermal Therapy
$287,696Chris John Diederich · University Of California, San Francisco · R01 · FY2009 · CA
Classification of ambiguous melanocytic tumors
$287,653University Of California San Francisco · R33 · FY2005 · CA
Immunization Against Melanoma Differentiation Antigens
$287,627Jedd D. Wolchok · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
Validation of genomic targets in melanoma
$287,615Mohammed Kashani-Sabet · University Of California, San Francisco · R01 · FY2007 · CA
CANCER AND LEUKEMIA GROUP B
$287,592University Of Chicago · U10 · FY2000 · CA
Melanoma RAS/BRAF Mutation: Heterogeneity-Risk-Prognosis
$287,571Nancy E Thomas · Univ Of North Carolina Chapel Hill · R01 · FY2009 · CA
Vaccines to promote Tc-1-based targeting of tumor stroma
$287,547Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · CA
MECHANISMS OF ALCOHOL RELATED INHIBITION OF NK ACTIVITY
$287,544Washington State University · R01 · FY2001 · AA
Oncogene c-Myc-dependent pathways in cutaneous melanoma
$287,527Mikhail Nikiforov · University Of Michigan At Ann Arbor · R01 · FY2007 · CA
Innate immunity to adenovirus vectors
$287,488Dmitry Shayakhmetov · University Of Washington · R01 · FY2007 · AI
Subcellular/Cell Cycle Boron-Delivery Studies of Unnatural Amino Acids by SIMS
$287,481Subhash Chandra · Cornell University · R01 · FY2011 · CA
Computational Design of Protein-Protein Interactions
$287,457Brian A Kuhlman · Univ Of North Carolina Chapel Hill · R01 · FY2017 · GM